|
19 Jun 2007 |
Diamyd diabetes study invalidated
|
|
19 Jun 2007 |
Phase I for Influenza vaccine adjuvanted with Intercell’s IC31(TM) started
|
|
19 Jun 2007 |
New Flu Vaccine From PepTcell Could Provide Immunity Against All Strains of Influenza Virus
|
|
18 Jun 2007 |
Hypertension vaccine CYT006-AngQb achieves strong blood
|
|
14 Jun 2007 |
Novartis gains European approval for its innovative flu vaccine Optaflu(R)
|
|
14 Jun 2007 |
GlaxoSmithKline's application for DTaP-IPV vaccine is accepted for review by the FDA
|
|
12 Jun 2007 |
Opexa Presents Tovaxin(TM) Research at Federation of Clinical Immunology Societies Annual Meeting
|
|
12 Jun 2007 |
Orchestra Therapeutics announces new Phase II clinical data on NeuroVAX (TM) demonstrating marked expansion of regulatory T Cell populations in patients with multiple sclerosis
|
|
08 Jun 2007 |
Mymetics' HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
|
|
07 Jun 2007 |
All patients are enrolled in Curalogic’s clinical EU phase III trial with the ragweed product
|
|
06 Jun 2007 |
Encouraging clinical activity of GSK's novel cancer immunotherapeutic confirmed in phase II study in patients with most common form of lung cancer
|
|
06 Jun 2007 |
IDM Pharma Presents Preliminary Results from Phase II UVIDEM(R) Melanoma Vaccine Clinical Trial
|
|
06 Jun 2007 |
Coley Pharmaceutical Group's Vaccine Adjuvant, VaxImmune, to Enter Phase III Clinical Testing as Part of GlaxoSmithKline's Novel Cancer Immunotherapeutic in Non-Small Cell Lung Cancer
|
|
05 Jun 2007 |
IDM Pharma Presents Interim Phase II Data From EP-2101 Lung Cancer Vaccine Clinical Trial
|
|
05 Jun 2007 |
Introgen Announces Positive Phase 2 Clinical Trial Results with INGN 225 Immunotherapy in Patients with Small Cell Lung Cancer
|
|
02 Jun 2007 |
Transgene to Receive First Milestone Payment of EUR 10 Million From Roche Following FDA and EMEA Review of TG 4001 (R3484) Phase III Studies Plan
|
|
02 Jun 2007 |
Vakzine Projekt Management Reports Positive Clinical Trial Results With Their Therapeutic Prostate Cancer Vaccine VPM4001
|
|
01 Jun 2007 |
Vaxfectin(TM)-formulated Measles DNA Vaccine Elicits Long-term Protection and Sterilizing Immunity in Nonhuman Primates
|
|
01 Jun 2007 |
Dendreon Announces FDA Confirms Data Required for Provenge(R) Licensure
|
|
26 May 2007 |
Iomai Announces Interim Results From Phase 1 Study of Its Patch-Based Vaccine for Seasonal Influenza
|
|
26 May 2007 |
MedImmune Receives Correspondence From FDA Regarding FluMist(R)
|
|
25 May 2007 |
Cytos Biotechnology reports results from a phase I/IIa study
|
|
25 May 2007 |
Celldex Therapeutics Initiates a Definitive Phase 2/3 Clinical Trial of CDX- 110 in Patients with Glioblastoma Multiforme
|
|
24 May 2007 |
VGX Pharmaceuticals' Novel HIV and Pandemic Influenza DNA Vaccine Candidates Trigger Robust Immune Responses and Protection in Pre-Clinical Models
|
|
23 May 2007 |
Enzo Biochem Individualized Oral Immune Regulation Therapy
|
